Yu-Lin Tan
Overview
Explore the profile of Yu-Lin Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding W, Wang Y, Shen C, Li J, Jiang H, Tan Y, et al.
Updates Surg
. 2025 Jan;
PMID: 39800788
Laparoscopic exploration of the common bile duct (CBD) has emerged as a predominant method in hepatobiliary surgery owing to its minimally invasive nature and favorable outcomes compared to traditional open...
2.
Liu Y, Tan Y, Li Y, Ping Y, He D, Zhang G, et al.
Front Plant Sci
. 2025 Jan;
15():1520363.
PMID: 39777088
The southeastern Yunnan is one of the most typical areas in China with karst landforms. The rich variety of vegetation types and plant diversity means that threatened status are also...
3.
Ding W, Chen W, Wang Y, Xu X, Wang Y, Yan Y, et al.
World J Gastrointest Oncol
. 2024 Mar;
16(2):458-474.
PMID: 38425400
Background: Gastric cancer (GC) is a prevalent malignant tumor of the gastrointestinal system. ZNF710 is a transcription factor (TF), and zinc finger protein 710 (ZNF710)-AS1-201 is an immune-related long noncoding...
4.
Yin L, Liu K, Lv W, Lu D, Tan Y, Wang G, et al.
Cancer Imaging
. 2023 May;
23(1):52.
PMID: 37254146
Objective: Local combined systemic therapy has been an important method for the treatment of unresectable hepatocellular carcinoma (HCC).The purpose of this study was to compare the effectiveness and safety of...
5.
Zhu Z, Yuan M, Yang P, Xie B, Wei J, Qin Z, et al.
World J Surg Oncol
. 2022 Jun;
20(1):192.
PMID: 35689233
Background: Microwave ablation (MWA) is a potentially curative treatment for unresectable patients with hepatocellular carcinoma (HCC) ≤ 3 cm, while its therapeutic efficacy decreases significantly for HCC > 3cm. Previous...
6.
Cheng H, Gong D, Zhao Z, He P, Yu X, Ye Q, et al.
Circ J
. 2022 Jan;
86(2):364.
PMID: 35082228
No abstract available.
7.
Liu S, Liu K, Lv W, Lu D, Zhu X, Jiang B, et al.
Front Med (Lausanne)
. 2021 Dec;
8:774345.
PMID: 34970563
Apatinib is a inhibitor of vascular endothelial growth factor receptor-2. To explore the efficacy and prognostic factors of transarterial chemoembolization (TACE) combined with apatinib in the treatment of Barcelona Clinic...
8.
Liu K, Lv W, Lu D, Hou C, Xie J, Lu Y, et al.
Cancer Manag Res
. 2021 Oct;
13:7973-7980.
PMID: 34703317
Purpose: To investigate the potential safety and efficacy of drug-eluting bead-transcatheter arterial chemoembolization (DEB-TACE) in treating TACE-refractory hepatocellular carcinoma (HCC). Methods: We retrospectively evaluated the treatment outcomes of DEB-TACE for...
9.
Yao F, Lv Y, Zhang M, Xie W, Tan Y, Gong D, et al.
Biochem Biophys Res Commun
. 2021 Aug;
575:99-100.
PMID: 34392958
No abstract available.
10.
Luo Z, Jiang X, Liu H, He L, Luo X, Chen F, et al.
Biochem Genet
. 2021 Jan;
59(2):604-616.
PMID: 33415668
Inflammatory responses play significant role in infectious etiology-induced acute lung injury (ALI). Histone deacetylase 2 is found to be essential and stimulated in lipopolysaccharide (LPS)-induced ALI by regulating proinflammatory cytokines....